Similar results were detected for 90‐day recurrent ischemic stroke (7.06% [51/722] DAPT versus 7.17% [18/251] intravenous t‐PA; aOR, 0.94; 95% CI, 0.52 to 1.70; p = 0.85; 6.78% [29/428] aspirin versus 7.17% [18/251] intravenous t‐PA; aOR, 0.94; 95% CI, 0.50 to 1.79; p = 0.85, respectively) (Table 2). This evidence concerns the gene PLAT and ischemic stroke.